Eric S. Finkelman

Chief Technical Officer at Vero Biotech

Mr. Finkelman has been an Operational and Product Development leader for over 25 years. He has led global teams in Operations, R&D, and Customer Service. He combines a Growth-Oriented mindset with lean leadership methodologies to build systems and cultures that enable the development of people, products, and processes.

Prior to joining VERO, Mr. Finkelman served as the V.P. of Global Operations and R&D at EndoChoice (Acquired by Boston Scientific). During his tenure, Mr. Finkelman oversaw all activities related to the Endoscopic Imaging platform, including direct oversight of the facilities in Germany and Israel. Mr. Finkelman served as the Vice President of Operations and R&D at Sierra Scientific Instruments, an NIH-funded startup that became the global GI diagnostic industry leader in high-resolution manometry and reflux monitoring. During Mr. Finkelman’s tenure, the organization commercialized its flagship ManoScan and DigiTrapper platforms. This business was acquired by Given Imaging before subsequently becoming part of Medtronic. In prior positions, Mr. Finkelman held both product development and operational leadership roles for both early-stage private organizations and larger public companies. Mr. Finkelman holds a B.S. in Mechanical Engineering from Rensselaer Polytechnic Institute and an M.S. in Manufacturing Engineering from the University of Southern California.

Timeline

  • Chief Technical Officer

    Current role

View in org chart